MedTrace Logo

Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients

NCT06125873 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-11-09

No results posted yet for this study

Summary

A randomized clinical trial will be done on 50 patients , randomly divided into two groups by lottery method to compare the glycemic control in patients of Type 2 Diabetes Mellitus by the use of Moringa Oleifera (MO) capsules. Patients will be given Moringa Oleifera (MO) capsules for 3 months and follow up will be conducted after 3 months to assess glycemic control.

Conditions

  • Diabetes Mellitus Type 2

Interventions

DRUG

Metformin

Moringa + Metformin - Moringa 1 gm and Metformin 500 mg

Sponsors & Collaborators

  • Islamabad Medical and Dental College

    lead OTHER

Principal Investigators

  • Yasiri Niazi, MD · IMDC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-05-01
Completion
2024-08-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06125873 on ClinicalTrials.gov